Purchase Order 36C26125P1603

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $65,000 firm fixed-price purchase order to Edwards Lifesciences LLC on September 18, 2025, for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which is not set-aside designated, will be performed in San Francisco, California, with a completion date of December 17, 2025. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, serves as the sole manufacturer and prime contractor for these specialized heart valve products essential to the VA's surgical programs.

This purchase order represents a continuation of Edwards Lifesciences LLC's established supply relationship with the VA, which includes two significant indefinite delivery contracts valued at $2.5 million and $1.25 million respectively. The company specializes in providing advanced transcatheter heart valves and cardiac implants to support the VA's structural heart disease treatment capabilities across multiple Veterans Integrated Service Networks. As a self-certified small disadvantaged business, Edwards Lifesciences LLC maintains a critical operational role in ensuring veteran access to state-of-the-art cardiovascular surgical technologies and maintaining necessary inventory of short shelf-life medical devices for on-demand surgical procedures.